BIT: ERFO Statistics

Total Valuation

Laboratorio Farmaceutico Erfo has a market cap or net worth of EUR 11.10 million. The enterprise value is 9.99 million.

Market Cap	11.10M
Enterprise Value	9.99M

Important Dates

The last earnings date was Friday, January 10, 2025.

Earnings Date	Jan 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Laboratorio Farmaceutico Erfo has 8.54 million shares outstanding. The number of shares has decreased by -5.14% in one year.

Current Share Class	n/a
Shares Outstanding	8.54M
Shares Change (YoY)	-5.14%
Shares Change (QoQ)	+4.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 25.16 and the forward PE ratio is 21.67. Laboratorio Farmaceutico Erfo's PEG ratio is 2.26.

PE Ratio	25.16
Forward PE	21.67
PS Ratio	1.91
PB Ratio	1.48
P/TBV Ratio	2.50
P/FCF Ratio	10.62
P/OCF Ratio	n/a
PEG Ratio	2.26

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.11, with an EV/FCF ratio of 9.56.

EV / Earnings	22.65
EV / Sales	1.72
EV / EBITDA	9.11
EV / EBIT	16.96
EV / FCF	9.56

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.05.

Current Ratio	1.86
Quick Ratio	1.25
Debt / Equity	0.05
Debt / EBITDA	0.36
Debt / FCF	0.38
Interest Coverage	19.96

Financial Efficiency

Return on equity (ROE) is 5.16% and return on invested capital (ROIC) is 4.41%.

Return on Equity (ROE)	5.16%
Return on Assets (ROA)	3.48%
Return on Capital (ROIC)	4.41%
Revenue Per Employee	149,293
Profits Per Employee	11,310
Employee Count	33
Asset Turnover	0.55
Inventory Turnover	3.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.25% in the last 52 weeks. The beta is 1.34, so Laboratorio Farmaceutico Erfo's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+16.25%
50-Day Moving Average	1.11
200-Day Moving Average	1.09
Relative Strength Index (RSI)	54.25
Average Volume (20 Days)	56,950

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Laboratorio Farmaceutico Erfo had revenue of EUR 5.82 million and earned 441,106 in profits. Earnings per share was 0.05.

Revenue	5.82M
Gross Profit	2.43M
Operating Income	588,934
Pretax Income	576,051
Net Income	441,106
EBITDA	1.10M
EBIT	588,934
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 1.52 million in cash and 398,015 in debt, giving a net cash position of 1.13 million or 0.13 per share.

Cash & Cash Equivalents	1.52M
Total Debt	398,015
Net Cash	1.13M
Net Cash Per Share	0.13
Equity (Book Value)	7.54M
Book Value Per Share	0.88
Working Capital	1.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.31 million and capital expenditures -265,796, giving a free cash flow of 1.05 million.

Operating Cash Flow	1.31M
Capital Expenditures	-265,796
Free Cash Flow	1.05M
FCF Per Share	0.12

Full Cash Flow Statement

Margins

Gross margin is 41.68%, with operating and profit margins of 10.11% and 7.58%.

Gross Margin	41.68%
Operating Margin	10.11%
Pretax Margin	9.89%
Profit Margin	7.58%
EBITDA Margin	18.83%
EBIT Margin	10.11%
FCF Margin	17.95%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 4.62%.

Dividend Per Share	0.06
Dividend Yield	4.62%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	5.14%
Shareholder Yield	9.76%
Earnings Yield	3.97%
FCF Yield	9.42%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Laboratorio Farmaceutico Erfo has an Altman Z-Score of 3.14.

Altman Z-Score	3.14
Piotroski F-Score	n/a